Therefore, this study has shown the synergism between 20(S)-Ginsenoside Rg3 and Sorafenib in the treatment of hepatocellular carcinoma through modulation of PTEN/AKT signaling [45]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.